{"id":"https://openalex.org/W2019409612","doi":"https://doi.org/10.1080/00032710902961073","title":"Time-Dependent and Sample-to-Sample Variations in Human Plasma Peptidome are Both Minimized Through Use of Protease Inhibitors","display_name":"Time-Dependent and Sample-to-Sample Variations in Human Plasma Peptidome are Both Minimized Through Use of Protease Inhibitors","publication_year":2009,"publication_date":"2009-06-20","ids":{"openalex":"https://openalex.org/W2019409612","doi":"https://doi.org/10.1080/00032710902961073","mag":"2019409612"},"language":"en","primary_location":{"id":"doi:10.1080/00032710902961073","doi":"https://doi.org/10.1080/00032710902961073","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00032710902961073","pdf_url":null,"source":{"id":"https://openalex.org/S152476886","display_name":"Analytical Letters","issn_l":"0003-2719","issn":["0003-2719","1532-236X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Analytical Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090060877","display_name":"David Craft","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146461966","display_name":"Becton Dickinson (United States)","ror":"https://ror.org/048vrgr14","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David Craft","raw_affiliation_strings":["BD Diagnostics, Franklin Lakes, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BD Diagnostics, Franklin Lakes, New Jersey, USA","institution_ids":["https://openalex.org/I146461966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052437531","display_name":"Jizu Yi","orcid":"https://orcid.org/0000-0002-8976-5207","observed_orcids":["https://orcid.org/0000-0002-8976-5207"]},"institutions":[{"id":"https://openalex.org/I146461966","display_name":"Becton Dickinson (United States)","ror":"https://ror.org/048vrgr14","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jizu Yi","raw_affiliation_strings":["BD Diagnostics, Franklin Lakes, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BD Diagnostics, Franklin Lakes, New Jersey, USA","institution_ids":["https://openalex.org/I146461966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007436679","display_name":"Craig A. Gelfand","orcid":"https://orcid.org/0009-0007-7349-7395","observed_orcids":["https://orcid.org/0009-0007-7349-7395"]},"institutions":[{"id":"https://openalex.org/I146461966","display_name":"Becton Dickinson (United States)","ror":"https://ror.org/048vrgr14","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig A. Gelfand","raw_affiliation_strings":["BD Diagnostics, Franklin Lakes, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BD Diagnostics, Franklin Lakes, New Jersey, USA","institution_ids":["https://openalex.org/I146461966"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090060877"],"corresponding_institution_ids":["https://openalex.org/I146461966"],"apc_list":null,"apc_paid":null,"fwci":0.3613,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.48979204,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"42","issue":"10","first_page":"1398","last_page":"1406"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.017899999395012856,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/peptide-stability","display_name":"peptide stability","score":0.7440000176429749},{"id":"https://openalex.org/keywords/sample-to-sample-variation","display_name":"sample-to-sample variation","score":0.5929999947547913},{"id":"https://openalex.org/keywords/preanalytical-variables","display_name":"pre-analytical variables","score":0.9079999923706055},{"id":"https://openalex.org/keywords/edta-plasma","display_name":"EDTA plasma","score":0.9089999794960022},{"id":"https://openalex.org/keywords/blood-collection-tubes","display_name":"blood collection tubes","score":0.8960000276565552}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9298115372657776},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.8049049377441406},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7303612232208252},{"id":"https://openalex.org/C3020134792","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Human plasma","level":2,"score":0.5134032964706421},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.4493636190891266},{"id":"https://openalex.org/C82706917","wikidata":"https://www.wikidata.org/wiki/Q10251","display_name":"Plasma","level":2,"score":0.44663989543914795},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.43230023980140686},{"id":"https://openalex.org/C2776575606","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Blood plasma","level":2,"score":0.41807684302330017},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.28902336955070496},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2660350203514099},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.0},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1080/00032710902961073","doi":"https://doi.org/10.1080/00032710902961073","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00032710902961073","pdf_url":null,"source":{"id":"https://openalex.org/S152476886","display_name":"Analytical Letters","issn_l":"0003-2719","issn":["0003-2719","1532-236X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Analytical Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W194771106","https://openalex.org/W1971654402","https://openalex.org/W2038241145","https://openalex.org/W2056213160","https://openalex.org/W2056467018","https://openalex.org/W2087746647","https://openalex.org/W2094229819","https://openalex.org/W2172116519","https://openalex.org/W4323053439"],"related_works":["https://openalex.org/W2038241145","https://openalex.org/W2418130694","https://openalex.org/W7099408681","https://openalex.org/W2032183031","https://openalex.org/W2100872422","https://openalex.org/W2071624868","https://openalex.org/W2114297201","https://openalex.org/W1971654402","https://openalex.org/W7100605529","https://openalex.org/W1619897426"],"abstract_inverted_index":{"In":[0],"the":[1,39,46,62],"current":[2],"study,":[3],"we":[4,56],"have":[5,57],"developed":[6],"a":[7,35],"method":[8],"to":[9,33],"measure":[10],"relative":[11],"peptide":[12],"stability":[13],"over":[14,65],"time":[15,66],"in":[16,51,61,70,95],"different":[17],"blood":[18],"collection":[19],"tubes.":[20],"Reversed-phase":[21],"chromatography":[22],"and":[23,91],"liquid":[24],"chromatography\u2013matrix-assisted":[25],"laser":[26],"desorption/ionization":[27],"were":[28],"performed":[29],"on":[30],"three":[31],"subjects":[32],"facilitate":[34],"deeper":[36],"look":[37],"into":[38],"plasma":[40,53,97],"peptidome.":[41],"The":[42],"data":[43],"further":[44],"support":[45],"importance":[47],"of":[48],"protease":[49,80,85],"inhibitors":[50,86],"stabilizing":[52],"samples.":[54,98],"Significantly,":[55],"revealed":[58],"subject-to-subject":[59],"variability":[60],"intrinsic":[63],"damage":[64],"that":[67,84],"is":[68],"possible":[69],"standard":[71],"EDTA":[72],"plasma,":[73],"with":[74],"such":[75],"variations":[76],"extensively":[77],"minimized":[78],"by":[79],"inhibitors.":[81],"We":[82],"conclude":[83],"can":[87],"simultaneously":[88],"improve":[89],"time-dependent":[90],"individual-dependent":[92],"preanalytical":[93],"variables":[94],"human":[96]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}